Abstract
It is now clear that several members of the nuclear receptor superfamily are co-expressed by macrophages, lymphocytes and other cell types that are involved in the regulation of inflammatory and immune responses. Peroxisome proliferator-activated receptors (PPAR) and nuclear liver X receptors (LXR) are members of this family known to be activated by lipid derived endogenous ligands (such as fatty acids, eicosanoids and cholesterol) and pharmacological ones. Here we review the biology of these nuclear receptors and highlight recent work that show that their activation can ameliorate inflammatory conditions, especially due to their effect on macrophage functions. The data discussed herein show the potential beneficial effect of targeting these nuclear receptors in order to improve the outcome of septic patients.
Keywords: Inflammation, fatty acids, liver-x receptors, nuclear receptor, peroxisome proliferator-activated receptors, sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Lipid-Activated Nuclear Receptors and Sepsis
Volume: 10 Issue: 3
Author(s): Thais Martins de Lima-Salgado, Luiz Monteiro Cruz and Heraldo Possolo Souza
Affiliation:
Keywords: Inflammation, fatty acids, liver-x receptors, nuclear receptor, peroxisome proliferator-activated receptors, sepsis
Abstract: It is now clear that several members of the nuclear receptor superfamily are co-expressed by macrophages, lymphocytes and other cell types that are involved in the regulation of inflammatory and immune responses. Peroxisome proliferator-activated receptors (PPAR) and nuclear liver X receptors (LXR) are members of this family known to be activated by lipid derived endogenous ligands (such as fatty acids, eicosanoids and cholesterol) and pharmacological ones. Here we review the biology of these nuclear receptors and highlight recent work that show that their activation can ameliorate inflammatory conditions, especially due to their effect on macrophage functions. The data discussed herein show the potential beneficial effect of targeting these nuclear receptors in order to improve the outcome of septic patients.
Export Options
About this article
Cite this article as:
Martins de Lima-Salgado Thais, Monteiro Cruz Luiz and Possolo Souza Heraldo, Lipid-Activated Nuclear Receptors and Sepsis, Endocrine, Metabolic & Immune Disorders - Drug Targets 2010; 10 (3) . https://dx.doi.org/10.2174/187153010791936937
DOI https://dx.doi.org/10.2174/187153010791936937 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tetracyclines and Pulmonary Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Vitamin D: A Pleiotropic Hormone with Possible Psychotropic Activities
Current Medicinal Chemistry Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy
Recent Patents on Anti-Infective Drug Discovery The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Current Neuropharmacology The Effects of Psychopharmacologic and Therapeutic Approaches on Neuro-imaging in Obsessive-compulsive Disorder
Current Neuropharmacology Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Novel Applications of Nanotechnology in Controlling HIV and HSV Infections
Current Drug Research Reviews Nanoparticle Enabled Drug Delivery Across the Blood Brain Barrier: in vivo and in vitro Models, Opportunities and Challenges
Current Pharmaceutical Biotechnology A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Galectin-9 in Cancer Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Short Review: Green Trends in Insect Control Edited by O Lopez and J. G. Fernandez- Bolanos
Current Green Chemistry Cytokine Network in Inflammatory Bowel Disease
Current Drug Targets - Inflammation & Allergy Vesicle Trafficking, Autophagy and Nanoparticles: A Brief Review
Current Nanomedicine Current Therapeutic Options for Alzheimers Disease
Current Genomics Development of Liposomes and Pseudovirions with Fusion Activity for Efficient Gene Delivery
Current Gene Therapy Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options
Current Pharmaceutical Design Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Biotechnological Approaches for Control of Listeria monocytogenes in Foods
Current Biotechnology The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry